BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/12/2024 3:43:32 AM | Browse: 125 | Download: 640
 |
Received |
|
2024-08-08 18:00 |
|
Peer-Review Started |
|
2024-08-08 18:00 |
|
First Decision by Editorial Office Director |
|
2024-09-11 01:57 |
|
Return for Revision |
|
2024-09-11 01:57 |
|
Revised |
|
2024-09-22 09:04 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-09-25 02:36 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-09-25 05:53 |
|
Articles in Press |
|
2024-09-25 05:53 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-09-26 07:08 |
|
Publish the Manuscript Online |
|
2024-10-12 03:43 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Recent developments in non-invasive methods for assessing metabolic dysfunction-associated fatty liver disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Anmol Singh, Aalam Sohal and Akash Batta |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Akash Batta, DM, MD, Assistant Professor, Department of Cardiology, Dayanand Medical College and Hospital, Tagore Nagar, Civil Lines, Ludhiana 141001, Punjab, India. akashbatta02@gmail.com |
| Key Words |
Non-invasive tests; Metabolic-associated fatty liver disease; Fibrosis-4 index; Magnetic resonance elastography; Enhanced liver fibrosis |
| Core Tip |
Fibrosis-4 index, enhanced liver fibrosis, and magnetic resonance elastography are among the non-invasive tests (NITs) recommended by the American Association for the Study of Liver Disease for evaluation of patients at risk for or with established metabolic dysfunction-associated fatty liver disease (MAFLD). The recent non-invasive biomarkers of metabolic liver disease and liver investigation: Testing marker utility in steatohepatitis projects, have helped validate NITs for the detection of liver fibrosis and have significantly improved the reliability of NIT panels. While omics-based biomarkers present exciting possibilities, they are still in the early stages of clinical validation. The integration and combined use of various NITs appear to be the future direction for a more effective and precise assessment of MAFLD. |
| Publish Date |
2024-10-12 03:43 |
| Citation |
Singh A, Sohal A, Batta A. Recent developments in non-invasive methods for assessing metabolic dysfunction-associated fatty liver disease. World J Gastroenterol 2024; 30(39): 4324-4328 |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i39/4324.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i39.4324 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
